Unified Patent Court (UPC) analytics are now available. Check here

IP Verse

Patent opposition analysis in Vaccines industry

In the competitive field of Vaccines, companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top opposing and opposed companies, and the most recent patents getting opposed. Stay informed on the latest developments in Vaccines technology and learn how to protect your intellectual property.

Get Comprehensive Patent Opposition Report for the Vaccines Industry

Gain strategic insights, uncover critical details, and make informed decisions with expert-backed analysis.

Get Your Report Now

Top companies filing patent oppositions

Explore the top companies that have filed the most patent oppositions in the technology industry.

CompanyTotal Oppositions
STRAWMAN43
PFIZER29
SANOFI28
JAMES POOLE28
KONIG SZYNKA TILMANN VON RENESSE20
BOULT WADE TENNANT19
REGENERON PHARMACEUTICALS18
MAIWALD17
DR H ULRICH DORRIES16
MARGARET DIXON15

Top companies facing patent oppositions

Explore the top companies that have faced the most patent oppositions in the technology industry.

CompanyTotal Oppositions
GLAXOSMITHKLINE BIOLOGICALS76
NOVARTIS50
CUREVAC46
CHUGAI SEIYAKU KABUSHIKI KAISHA42
REGENERON PHARMACEUTICALS42
F HOFFMANN LA ROCHE39
SANOFI BIOTECHNOLOGY38
GENENTECH31
THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA29
AMGEN28

Top active law firms filing patent oppositions New

Explore the top law firms that have filed the most patent oppositions in the technology industry.

CompanyTotal Oppositions Filed
CARPMAELS & RANSFORD58
HOFFMANN EITLE44
MEWBURN ELLIS39
MAIWALD33
D YOUNG31
DORRIES, HANS ULRICH , DF-MP DORRIES FRANK-MOLNIA & POHLMAN29
J A KEMP28
KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORF27
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB27
ZWICKER24

Latest patents opposed in the Vaccines industry

Patent challenges are becoming increasingly common in the Vaccines industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Vaccines industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Vaccines industry

EP3678654Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein ConjugatesMERCK SHARP & DOHMEMar 18, 2025SANOFI PASTEUR
EP3678654Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein ConjugatesMERCK SHARP & DOHMEMar 17, 2025BIOLOGICAL E
EP3507369Anti-Cd20 AntibodyBEIJING MABWORKS BIOTECHMar 12, 2025ARROWHOUSE
EP3507369Anti-Cd20 AntibodyBEIJING MABWORKS BIOTECHMar 11, 2025KARO
EP3237004Predicting Outcome Of Treatment With An Anti- 4 7 Integrin AntibodyMILLENNIUM PHARMACEUTICALSFeb 7, 2025POLPHARMA BIOLOGICS
EP3167888Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of ComplementALEXION PHARMACEUTICALSJan 31, 2025SALUTE HC ILAC PAZARLAMA
EP3270966Combination Of Hdac Inhibitor And Anti-Pd-1 Antibody For Treatment Of CancerSYNDAX PHARMACEUTICALSJan 31, 2025MAIWALD
EP3515475Chimeric Antigen Receptor (Car) That Targets Chemokine Receptor Ccr4 And Its UseTHE USA REPRESENTED BY THE SECRETARYJan 30, 2025WEICKMANN & WEICKMANN PARTMBB
EP3215166Altering Gene Expression In Cart Cells And Uses ThereofTHE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAJan 24, 2025STRAWMAN
EP3411476Enhanced Production Of ImmunoglobulinsTRIANNIJan 24, 2025REGENERON PHARMACEUTICALS

Top patents facing oppositions in Vaccines industry

To stay ahead in the competitive Vaccines industry, companies are constantly innovating. Here are the top patents facing oppositions in the Vaccines industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Patent NumberGrant DateTitleApplicantTotal Oppositions
EP3177645Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLINDIS BIOTECH10
EP3616720Feb 17, 2021Pharmaceutical Composition For Cancer TreatmentSHIONOGI10
EP3322731Jan 13, 2021Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBB9
EP2766040May 15, 2019Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHE9
EP2780375Sep 11, 2019Binding Molecules For Bcma And Cd3AMGEN RESEARCH MUNICH8
EP3515465Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorSANOFI BIOTECHNOLOGY7
EP3283059Jan 3, 2024Method For Producing Rna CompositionsCUREVAC7
EP2780374Aug 21, 2019Binding Molecules For Bcma And Cd3AMGEN RESEARCH MUNICH7
EP3338794Feb 26, 2020Toxicity Management For Anti-Tumor Activity Of CarsTHE CHILDRENS HOSPITAL OF PHILADELPHIA7
EP3498734Sep 1, 2021Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating CancerMERCK SHARP & DOHME7